Literature DB >> 26088912

Intra-abdominal candidiasis: it's still a long way to get unquestionable data.

Philippe Montravers1, Olivier Leroy, Christian Eckmann.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26088912     DOI： 10.1007/s00134-015-3894-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  Clinical trials of antifungal prophylaxis among patients undergoing surgery.

Authors:  Thierry Calandra; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2004-10-15       Impact factor: 9.079

2.  Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients.

Authors:  Hervé Dupont; Catherine Paugam-Burtz; Claudette Muller-Serieys; Lisiane Fierobe; Denis Chosidow; Jean-Pierre Marmuse; Jean Mantz; Jean-Marie Desmonts
Journal:  Arch Surg       Date:  2002-12

3.  A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units.

Authors:  P Montravers; J-P Mira; J-P Gangneux; O Leroy; O Lortholary
Journal:  Clin Microbiol Infect       Date:  2010-10-19       Impact factor: 8.067

4.  A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

Authors:  Matteo Bassetti; Elda Righi; Filippo Ansaldi; Maria Merelli; Cecilia Trucchi; Trucchi Cecilia; Gennaro De Pascale; Ana Diaz-Martin; Roberto Luzzati; Chiara Rosin; Leonel Lagunes; Enrico Maria Trecarichi; Maurizio Sanguinetti; Brunella Posteraro; Jose Garnacho-Montero; Assunta Sartor; Jordi Rello; Giorgio Della Rocca; Massimo Antonelli; Mario Tumbarello
Journal:  Intensive Care Med       Date:  2014-05-08       Impact factor: 17.440

5.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

Authors:  Olivier Leroy; Jean-Pierre Gangneux; Philippe Montravers; Jean-Paul Mira; François Gouin; Jean-Pierre Sollet; Jean Carlet; Jacques Reynes; Michel Rosenheim; Bernard Regnier; Olivier Lortholary
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

6.  A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.

Authors:  Matteo Bassetti; Monia Marchetti; Arunaloke Chakrabarti; Sergio Colizza; Jose Garnacho-Montero; Daniel H Kett; Patricia Munoz; Francesco Cristini; Anastasia Andoniadou; Pierluigi Viale; Giorgio Della Rocca; Emmanuel Roilides; Gabriele Sganga; Thomas J Walsh; Carlo Tascini; Mario Tumbarello; Francesco Menichetti; Elda Righi; Christian Eckmann; Claudio Viscoli; Andrew F Shorr; Olivier Leroy; George Petrikos; Francesco Giuseppe De Rosa
Journal:  Intensive Care Med       Date:  2013-10-09       Impact factor: 17.440

Review 7.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.

Authors:  Benoît P Guery; Maiken C Arendrup; Georg Auzinger; Elie Azoulay; Márcio Borges Sá; Elizabeth M Johnson; Eckhard Müller; Christian Putensen; Coleman Rotstein; Gabriele Sganga; Mario Venditti; Rafael Zaragoza Crespo; Bart Jan Kullberg
Journal:  Intensive Care Med       Date:  2008-10-30       Impact factor: 17.440

8.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.

Authors:  Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

9.  β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.

Authors:  Frederic Tissot; Frederic Lamoth; Philippe M Hauser; Christina Orasch; Ursula Flückiger; Martin Siegemund; Stefan Zimmerli; Thierry Calandra; Jacques Bille; Philippe Eggimann; Oscar Marchetti
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

10.  Monitoring treatment response in abdominal sepsis with procalcitonin--if only!

Authors:  Christian Eckmann; Miguel Sanchez-Garcia
Journal:  Crit Care       Date:  2013-12-10       Impact factor: 9.097
View more
  6 in total

1.  Penetration of Ibrexafungerp (Formerly SCY-078) at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model.

Authors:  Annie Lee; Brendan Prideaux; Matthew Zimmerman; Claire Carter; Stephen Barat; David Angulo; Véronique Dartois; David S Perlin; Yanan Zhao
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  [Antibiotic therapy of intra-abdominal infections in the era of multiresistance].

Authors:  C Eckmann
Journal:  Chirurg       Date:  2016-01       Impact factor: 0.955

3.  Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis.

Authors:  Ting Yan; Shuang-Ling Li; Hai-Li Ou; Sai-Nan Zhu; Lei Huang; Dong-Xin Wang
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

4.  What every intensivist should know about the management of peritonitis in the intensive care unit.

Authors:  Jan J De Waele
Journal:  Rev Bras Ter Intensiva       Date:  2018-03

5.  Therapeutic Potential of Fosmanogepix (APX001) for Intra-abdominal Candidiasis: from Lesion Penetration to Efficacy in a Mouse Model.

Authors:  Annie Lee; Ning Wang; Claire L Carter; Matthew Zimmerman; Véronique Dartois; Karen Joy Shaw; David S Perlin; Yanan Zhao
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

6.  Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment.

Authors:  Pascalis Vergidis; Cornelius J Clancy; Ryan K Shields; Seo Young Park; Brett N Wildfeuer; Richard L Simmons; M Hong Nguyen
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.